Telehealth Medication Abortion

DMPA on TikTok, OTC pill sales, Misoprostol & IUD placements, Telehealth abortion & TGD populations, Abortion restrictions & infant mortality

Contraceptive knowledge gaps, Adolescent awareness of OTC contraception, DMPA and meningioma risk, Implicit bias in contraception counseling, PrEP & STI Risk

HPV self-collection, asynchronous telehealth abortion studies, young people and permanent contraception access, clinician confidence gaps in abortion navigation, shifting contraceptive preferences postpartum

Partner treatment for BV, pain and bleeding experiences during first-trimester abortion, interest in Rh testing and treatment for telehealth medication abortion.

Clinical trial data on a new IUD, clinical guidance on self-managed abortion, the impact of the ACA on reproductive health, and CDC’s abortion surveillance data.

U.S. MEC and U.S. SPR, standard dosing of UPA EC for people of all body sizes, birth control information on TikTok, and safety of medication abortion without screening ultrasound.

How health care providers can support improved access to this important birth control method.

Factors that increase risk for deep or nonpalpable implant, 12-hour vs. 24-hour mifepristone-misoprostol interval, and two studies reinforcing the safety and efficacy of no-test medication abortion.